Effort During Resistance Training in Type 2 Diabetes

Launched by UNIVERSITY OF NEW MEXICO · Jul 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how different levels of effort during resistance training, like lifting weights, can affect blood sugar control and mental well-being in people with type 2 diabetes. The researchers want to find out if exercising harder or easier makes a difference in managing diabetes and how it impacts participants' feelings. They are also looking at how many people stick with the program or decide to leave it and why that happens.

To join the study, participants need to be living with type 2 diabetes. However, certain health conditions, like serious heart problems or recent surgeries that could prevent exercise, could make someone ineligible. During the trial, participants will engage in resistance training sessions and report on their experiences. This could be a great opportunity for those interested in improving their health through exercise while contributing to important research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Living with type 2 diabetes mellitus
• Exclusion Criteria:
• • Have a significant cognitive impairment,
• • Are non-ambulatory,
• • Have lower extremity amputation,
• • Have renal failure,
• • Have liver disease,
• • Have uncontrolled hypertension (\>160 mmHg systolic and/or \>100 mmHg diastolic),
• • Have unstable cardiovascular disease,
• • Have a history of severe cardiovascular problems,
• • Have decompensated heart failure,
• • Have uncontrolled arrhythmias,
• • Have severe pulmonary hypertension (mean pulmonary arterial pressure \>55 mm Hg),
• • Have severe and symptomatic aortic stenosis,
• • Have acute myocarditis, endocarditis, or pericarditis,
• • Have aortic dissection,
• • Have Marfan syndrome,
• • Have unrepaired aortic aneurysm,
• • Have proliferative diabetic retinopathy,
• • Have rapidly progressive terminal illness,
• • Are unable to perform resistance exercise to due preexisting musculoskeletal conditions (e.g., joint pain, chronic injury or tendinopathy),
• • Are under biguanide (metformin) treatment, but are taking for less than 3 months,
• • Have taken drugs known to increase the risk of tendon disorders (e.g., tendinopathy and tendon rupture) within the last 6 months. These drugs include, but may not be limited to: fluoroquinolones, glucocorticoids, aromatase inhibitors, anabolic steroids, antiretrovirals, isotretinoin, cephalexin, rituximab, sitagliptin, cephalosporins, azithromycin, and sulfonamides.
• • Are pregnant or trying to become pregnant during the study,
• • Are prisoners,
• • Are persons that require a legally authorized representative.
• Temporary exclusions include:
• • Being subjected to recent surgeries for which resistance training is not recommended,
• • Have symptomatic hernias,
• • Have acute illness,
• • Have recent fractures, or other injuries until resolved.